LBX Pharmacy Chain Joint Stock (603883.SS) Earnings Analysis
LBX Pharmacy Chain Joint Stock (603883.SS) next reports earnings on 2026-08-28, consensus EPS 0.234 CNY. Last quarter (2026-04-24) it beat with EPS 0.35 CNY vs 0.3436 CNY est (+1.9%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 23.73.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603883.SS next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | 0.234 CNY |
| Revenue estimate | 5.74B |
603883.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-24 | 0.35 CNY | 0.3436 CNY | +1.9% | Beat |
| 2026-04-22 | -0.19313 CNY | 0.325 CNY | -159.4% | Miss |
| 2025-03-30 | 0.33 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.24 CNY | 0.32 CNY | -25% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
603883.SS valuation and analyst view
| Trailing P/E | 23.73 |
|---|---|
| Trailing EPS | 0.52405 CNY |
| Price / book | 1.37 |
| Dividend yield | 3.32% |
| Market cap | 9.33B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is LBX Pharmacy Chain Joint Stock (603883.SS)'s next earnings date?
LBX Pharmacy Chain Joint Stock is next scheduled to report on 2026-08-28, with a consensus EPS estimate of 0.234 CNY and revenue estimate of 5.74B.
Did 603883.SS beat earnings last quarter?
In its 2026-04-24 report, 603883.SS posted EPS of 0.35 CNY versus a 0.3436 CNY estimate — a beat of 1.9%.
What is 603883.SS's earnings track record?
Over the last 3 reported quarters with consensus data, 603883.SS beat estimates 1 times (33%).
What is 603883.SS's current P/E ratio and EPS?
603883.SS trades at a trailing P/E of 23.73 on trailing EPS of 0.5240481856714926 CNY.
What do analysts rate 603883.SS?
603883.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.